GlassScriptPhysician profile
Tamara A Keesee
NPI 1114437902
$8,926.11
in general payments reported to CMS, 2019-2025
19 companies · $1,603 in 2025
The $1,603 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $654 · 2022: $2,540 · 2023: $1,588 · 2024: $2,541 · 2025: $1,603.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,184 · Travel and Lodging: $2,548.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,184.35 |
| Travel and Lodging | $2,547.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $2,604.06 | 2021-2024 | Senza |
| Pacira Pharmaceuticals Incorporated | $1,803.15 | 2022-2025 | Iovera |
| Boston Scientific Corporation | $1,217.11 | 2021-2025 | Wavewriter Alpha Prime 16, General - Therapies, General - Pain Management |
| Medtronic, INC. | $853.03 | 2022-2025 | Intellis Adaptivestim, Inceptiv, Accurian |
| Abbvie INC. | $578.33 | 2021-2024 | |
| Amgen INC. | $363.32 | 2022-2024 | Otezla, Repatha |
| Astrazeneca Pharmaceuticals LP | $347.45 | 2021-2022 | |
| Abbott Laboratories | $216.02 | 2022-2025 | Proclaim |
| Biotronik Nro, INC. | $213.89 | 2025 | Prospera |
| Stryker Corporation | $160.08 | 2025 | Omnicurve, Mild Device Kit |
| Teva Pharmaceuticals USA, INC. | $119.05 | 2023 | Austedo Xr |
| Lilly USA, LLC | $105.54 | 2022 | |
| Foundation Fusion Solutions, LLC | $99.84 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $91.18 | 2022 | |
| Novo Nordisk INC | $50.07 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $31.81 | 2025 | |
| Saluda Medical Americas, INC. | $29.94 | 2024 | Evoke |
| Relievant Medsystems, INC. | $22.53 | 2022 | |
| Spinal Simplicity, LLC | $19.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamara Keesee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.